Keywords: fda, regulatory, news, brief, collagenex, received, second

FDA Regulatory News In Brief

Article | 04 February 1998

Print This

CollaGenex has received a second action letter from the US Food andDrug Administration regarding Periostat (doxycycline) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in